Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Other OTC
  5. Synaptogenix, Inc.
  6. Summary
    SNPX   US87167T1025

SYNAPTOGENIX, INC.

(SNPX)
 SummaryChartsNewsCompany 
All news about SYNAPTOGENIX, INC.
05/19SYNAPTOGE  : Synaptogenix Announces Plan to Uplist on the Nasdaq Stock Market
PR
05/14SYNAPTOGE  : SYNAPTOGENIX, INC. Management's Discussion and Analysis of Financia..
AQ
05/10SYNAPTOGENIX, INC : Invitation to the Benzinga Global Small Cap Conference
NE
04/30SYNAPTOGENIX, INC.  : Financial Statements and Exhibits (form 8-K)
AQ
04/26SYNAPTOGENIX  : to Present at Sachs 4th Annual Neuroscience Innovation Forum
PR
04/08SYNAPTOGENIX, INC.  : Change in Directors or Principal Officers, Submission of M..
AQ
04/01SYNAPTOGENIX  : Announces Phase 2b Bryostatin-1 Clinical Trial Update
PR
03/30SYNAPTOGE  : SYNAPTOGENIX, INC. Management's Discussion and Analysis of Financia..
AQ
02/17SYNAPTOGENIX, INC.  : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
02/12SYNAPTOGENIX  : to Participate in the Winter Wonderland - Best Ideas from the Bu..
PR
02/04SYNAPTOGENIX  : Synthetic Bryostatin Available to Expand Neurodegenerative Indic..
PR
01/22SYNAPTOGENIX, INC.  : Entry into a Material Definitive Agreement, Unregistered S..
AQ
01/19SYNAPTOGENIX, INC.  : Entry into a Material Definitive Agreement, Material Modif..
AQ
2020SYNAPTOGENIX  : Management's Discussion and Analysis of Financial Condition and ..
AQ
2020SYNAPTOGENIX, INC.  : Regulation FD Disclosure, Financial Statements and Exhibit..
AQ
More news
News in other languages on SYNAPTOGENIX, INC.

- No features available -

More news
Chart SYNAPTOGENIX, INC.
Duration : Period :
Synaptogenix, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Managers and Directors
NameTitle
Alan J. Tuchman Chief Executive Officer & Director
Daniel L. Alkon President, Director & Chief Science Officer
Robert Weinstein Chief Financial Officer, Secretary & Treasurer
Joshua Nathaniel Silverman Chairman
William S. Singer Vice Chairman